BioOra, New Zealand’s pioneering licensed contract and development manufacturer of CAR T cell therapeutics, has successfully raised an impressive $4 million in funding to advance its groundbreaking work in cell therapy. This significant investment underscores the growing recognition of BioOra's unique capabilities and commitment to delivering cutting-edge therapeutics to patients worldwide. With a world-class team of scientists and industry consultants, BioOra is dedicated to streamlining the journey of CAR T cell therapies – from patient blood isolation to the crucial stage of infusion. The newly acquired funds will enable the company to enhance its manufacturing processes, further control costs, and expedite timelines, ultimately allowing for faster patient access to vital therapies. In addition to bolstering operational efficiency, BioOra plans to invest in continuous improvement initiatives that will strengthen their already robust capabilities as they advance therapies through commercialization. This investment not only marks a significant milestone in BioOra’s growth but also reflects the company's unwavering commitment to innovation in the field of cell therapy. As it forges ahead, BioOra is poised to reshape the landscape of CAR T cell treatments, ensuring that therapeutic advancements are both accessible and adaptable to the evolving needs of patients globally. With this funding, BioOra is not just investing in its future – it is investing in the future of medicine.
BioOra Secures $4 Million in Funding to Revolutionize CAR T Cell Therapeutics Manufacturing in New Zealand
Recently funded · $4.0MHealthcare
Get the full BioOra company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Laihua Online
Wuhan Laihua Information and Technology is an Internet leading source of information on educational opportunities for students to study in other countries especially in China. Either prospect is planning to come to China or is already in China for education (self-support or scholarship based) he will probably need one of the ranges of services we provide from Education, Translation, Notarization of legal documents to Internships & Jobs or Medical Tourism etc. It is a comprehensive directory of study abroad programs, including summer study abroad, service learning, intensive language programs and more. Wuhan Laihua Information and Technology first set out to fill the information gap between students with a desire to travel abroad to study and companies offering international programs.
$68.0M Series d
today
NEW ID
NEW ID is the latest subsidiary company of NEW, which has started up since August 2019 for a new digital contents/platform business domain. We are responsible for expanding the contents produced and acquired by NEW into various markets and creating our digital capabilities through partnering with a-lister digital content creators and providers in Korea.
